Summary of opinion: Loargys,Pegzilarginase, 12/10/2023, Positive
On 12 October 2023, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation under exceptional circumstances1 for the medicinal product Loargys2, intended for the treatment …